27 April 2017
- Autism could now be added to the lengthy and perpetually-expanding list of afflictions and symptoms treatable with the one product of nature shamefully prohibited by the federal government — the “miracle” palliative, cannabis.
One in every 68 children in the United States is now affected by autism, and the number of kids coping with the developmental disorder has been increasing at an explosive rate in recent years. With onset most common during infancy and early childhood, autism can impact social and communication skills and may cause repetitive or compulsive behaviors, among other manifestations.
Now, fresh evidence again frowns upon U.S. federal prohibition of cannabis — listed as a Schedule I dangerous substance of no potential medical use, alongside heroin — which could be depriving ailing children the chance for treatment, and hope for a better-adjusted future.
25 April 2017
- “Cannabis brings us an awareness that we spend a lifetime being trained to overlook and forget and put out of our minds.” — Carl Sagan
Most of us remember Carl Sagan as a brilliant scientist, a popularizer of both the methods and progress of human knowledge. Some know him as an advocate of space exploration and peace on earth. Some will even recognize his brilliant work in the science fiction community, as a writer himself, and as a commentator on sci-fi authors such as Arthur C. Clarke.
Few, however, know that he wrote an absolutely thrilling and insightful essay on the merits of the psychoactive properties of the cannabis plant.
Writing under the pseudonym ‘Mr. X’ (due to the political sensitivity of coming out as a smoker), Carl starts out by going into the well-known sensory enhancements bestowed by cannabis, most notably those which occur during sex, while listening to music, and while savoring art.
13 April 2017
- Today Canada’s Prime Minister, Justin Trudeau, introduced legislation to legalize marijuana in Canada. But not just medical marijuana – recreational marijuana. A milestone in the country’s history and one for the world, too.
While many countries have decriminalized or allowed the medical use of marijuana, Trudeau’s bill – which is expected to pass – will make Canada the second nation after Uruguay to completely legalize cannabis for consumers. Media is warning that “experts” are working out the kinks before sales can begin. Each province will decide how marijuana can be distributed and sold within its territory, including prices and age limits.
Since this effort surrounds legalization versus decriminalization, Canadians can probably expect high taxes and regulation on the product, similar to Canada’s strict tobacco regulations and government-run liquor stores. However, unlike America, where marijuana is legal in some states but still federally illegal (fueling the War on Drugs and police state policies), Canada’s expected ruling will eliminate a national prohibition.
21 March 2017
- A company focused on the healing power of cannabis came out with an effective patch that relieves fibromyalgia symptoms and diabetic nerve pain.
With this knowledge on hand, cannabis deserves a better reputation that the one it already has.
The cannabis patches are nothing but transdermal patches that release the “good stuff” in the skin, which later travel through the bloodstream. These patches relieve neurological nerve pain caused by diabetes and fibromyalgia. Experts from the company explain that controlled doses can’t harm the body nor cause any side effects.
17 March 2017
- Vincenzo Fornaro’s farm is less than a mile from the steel mill. His entire stash of 600 sheep had to be killed over a decade ago, and he’s since been forbidden from raising livestock or crops for food. So instead, as CBS News reported, he’s growing weed—not to smoke or to sell, but to pull the steel mill’s toxins out of his soil.
Fornaro has planted massive stands of industrial hemp on his farm. He’s employing a tactic called “phytoremediation,” in which plants are used to remove heavy metals, radioactive material and other bad stuff from the earth.
Industrial hemp has been used to clean up deadly pollutants before, perhaps most famously near the site of the deadly nuclear meltdown at Chernobyl in what is now Ukraine (and where, it should not go unstated, thousands of people are still at work at the power station, which produces six percent of the nation’s electricity). In the mid-1990s, a company called Phytotech worked with researchers and a Ukraine-based seed bank to plant thousands of hemp plants in and around Chernobyl.
24 January 2017
- Recent findings that have been published in Frontiers in Pharmacology have indicated that marijuana does, indeed, improve cognitive performance.
Researchers from McLean Hospital, Harvard Medical School, and Tufts University have begun preliminary investigations that have found incredible benefits from the plant's use, including the improvement to "our ability to utilize the knowledge acquired by mental processes in our brains.”
24 patients were studied over a three-month history. The patients were consistently measured with cognitive testing, including the Stroop Color Word Test and the Trail Making Test.
15 January 2017
- Ibogaine works wonders with opioid addiction, but you have to go to another country to get access to it.
State legislators, medical marijuana patients, doctors and adult cannabis consumers have been stymied in many ways by the federal listing of cannabis as a schedule 1 controlled substance. However, cannabis is not unique in that regard.
For example, another powerful medicine plant, the iboga shrub, is likewise banned from medical use. What makes iboga a special case is that its major medical value has been as an effective treatment for addiction to alcohol and hard drugs.
Once again, the Drug War that is supposed to prevent addiction is used instead to withhold treatment from those who most need it.
29 December 2016
- The latest marijuana benefits just discovered are that it can treat bone fractures and also help in organ transplants.
It is now clear that marijuana has a medicinal value, with some researchers constantly using what little resources they have to demonstrate the point. The results from such studies are amazing, showing a remarkable efficacy of the plant.
But despite these encouraging findings, the plant still remains illegal in a country where, if it is legalized, could have a significant impact on the rest of the world.
6 December 2016
- In June 2015 we reported on the re-emerging field of using psychedelics to treat mental illness, with psilocybin, in particular, showing great promise for chronic anxiety and depression. Western medicine began realizing its potential in the 1940s, but medical research was stamped out with the War on Drugs.
Now, as the injustice of the drug war is fully exposed, research is again turning to the amazing, natural power of psilocybin. William Richards at Johns Hopkins University has been dosing people with psilocybin for 15 years, and in 2006 published his first study demonstrating positive therapeutic results.
That study provided the impetus for a rapid expansion in psychedelic research. On December 1, results of the first two major clinical trials were published in the Journal of Psychopharmacology – showing yet again psilocybin’s remarkable effect on depression and end-of-life stress.
10 November 2016
- The 2016 U.S. election shocked everyone. But while the results did not look like anything pundits and pollsters predicted, American voters stayed mostly consistent on at least one subject: marijuana.
Prohibitive anti-marijuana laws across the country suffered a major setback on November 8, when voters in California, Massachusetts, Maine, and Nevada approved the legalization of recreational cannabis. Arizona, however, wasn’t as pro-freedom, as just over 52 percent of Grand Canyon state voters said no to Proposition 205. A powerful lobby backed the opposition in that state.
In Florida, Arkansas, Montana, and North Dakota, voters passed medical marijuana laws, allowing patients suffering from certain medical conditions to have access to cannabis.
25 October 2016
- Cannabis and Hemp (which is the more industrial version of Cannabis) have proven time and time again to be billion-dollar cash crops.
The States that have legalized their use have seen an astounding increase in tax revenue created by the plant.
We know it has at least 50,000 known uses, and we’ve been using Cannabis for many of those things since before we even started recording human history.
We know all about how to use it’s leaves, its fiber, leaves, flowers, oils, resins, etc.. But when it comes to the roots of the plant, they tend to get overlooked.
The first mention of hemp root as medicine can be found in the ancient Chinese pharmacopoeia, the Shen Nung Pên-ts’ao Ching, as early as the third millennium BCE.
19 October 2016
- Following months of negotiations and various offers, Germany-based Bayer has finally sealed the deal with Monsanto, purchasing the seed giant for $66 billion. The merger is reported to be the largest all-cash deal on record.
The purchase means a lot of things, and none of them good for consumers. For one, it strengthens the monopolization of the world's food supply. It also means more genetically modified organisms (GMOs) and chemicals to be doused on them.
Now, some are predicting the merge could also mean the takeover of the marijuana industry. Monsanto has an intimate business relationship with Scotts Miracle-Gro, "a convicted corporate criminal– and Scott's Miracle-Gro is trying to take over the marijuana industry," according to Big Buds Mag.
14 October 2016
- In a stunning reversal, the DEA has withdrawn its proposal to ban kratom and temporarily suspended efforts to make it a Schedule 1 drug. The move comes after an impassioned Internet-based protest by a decentralized network of advocates and activists who contend the southeast Asian plant has tremendous medicinal value. While not a permanent ruling, the reversal is extremely unusual for the government agency, which is known for aggressive enforcement of its drug policies.
DEA spokesperson Melvin Patterson confirmed that the intense public reaction fueled the decision. “That was eye-opening for me personally,” he said.“I want the kratom community to know that the DEA does hear them. Our goal is to make sure this is available to all of them.”